Items of recent pandemic news you may have missed: What the delta variant actually does (hint: it doesn’t “transmit” better); about correlates of protection; and the unresolved question of how the J&J vaccine works against delta. Plus a frippery. J&J … Continue reading →
Nine items of recent pandemic news you may have missed: Rapid testing, mixing and matching vaccines, booster shots, the genetics predicting severe Covid-19, another blow to J&J, some mechanisms behind neurological damage, and more. Plus a frippery. 1. Pfizer wants … Continue reading →
Items of recent pandemic news you may have missed: The animals sold in Wuhan’s wet markets; animal reservoirs for SARS-CoV-2; and animal vaccinations. Plus the usual frippery, this one animal-themed as well. A vaccine for zoo animals We have discussed … Continue reading →
This week the Update moves from its former strictly biweekly cadence to a weekly format; each issue will encompass a larger number of brief items. There may occasionally be longer features. Fear not, the frippery is here to stay. mRNA … Continue reading →
Two items of recent pandemic news: The FDA says myocarditis is a rare side effect of mRNA vaccines; and a scientist recovers early Wuhan genetic sequences that went missing last year for unknown reasons. Plus news briefs and a frippery. … Continue reading →
Three items of recent pandemic news: Human trials near for an inhalable antiviral; rumors of bad behavior by Google with an infection-tracking and notification app; and the WHO recommends against vaccinating children. Plus a news brief and a frippery. WHO … Continue reading →
Two items of recent pandemic news: Billions to develop antivirals that can be taken by mouth; and a hard fail in a vaccine Phase III trial. Plus news briefs and a frippery. CureVac falls flat You may have heard by … Continue reading →
Three items of recent pandemic news: the seriousness of the Delta variant; how a bitter taste might predict the severity of a Covid-19 outcome; and results from the Novavax Phase III trial. Plus news briefs and a frippery. Novavax results … Continue reading →
Three items of pandemic news: Long Covid in children; an FDA panel confirms an excess of heart inflammation following mRNA vaccination; and how the American tendency to individualism over collectivism hamstrung our pandemic response. Plus news briefs and a frippery. … Continue reading →
Herewith two items of recent pandemic news: Some clarity on long Covid and its relation to two known autonomic conditions; and watching for cases of heart inflammation in young men after mRNA vaccination. Plus news briefs and a frippery. Teens, … Continue reading →
Items of recent pandemic news: Moderna applies to the FDA for full licensure; Minnesota and the Twin Cities end mask mandates; and cautious optimism that the pandemic is ending in the US. Plus news briefs and a brace of fripperies. … Continue reading →
Herewith a brief issue, as pandemic news has been thin over a holiday weekend. No news briefs today but of course there’s a frippery. WHO tackles naming the variants The designations given to the viral variants are not friendly; the … Continue reading →
Two items of recent pandemic news: Studies point to long-lasting, possibly lifelong immunity from natural infection; and rapid developments in the highly political question of where SARS-CoV-2 came from. Plus news briefs and a pair of fripperies. Origin, again It … Continue reading →
Items of recent pandemic news: Moderna’s vaccine works in those 12 to 17 years old; the political nature of college mandates to vaccinate returning students; and a new, fast-spreading variant out of India. Plus news briefs and a frippery. B.1.617.2 … Continue reading →
Three items of recent pandemic news: Pfizer’s vaccine can keep for 30 days at refrigerator temperatures; neutralizing antibody levels emerge as a correlate of protection; and the long stretch of post-trauma grief that awaits us. Plus news briefs and a … Continue reading →
